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SUMMARY
Purpose: FDG PET hypometabolism is important for surgical planning in patients with temporal
lobe epilepsy (TLE), but its significance remains unclear in patients who do not have evidence of
mesial temporal sclerosis (MTS) on MRI. We examined surgical outcomes in a group of PETpositive, MRI-negative patients and compared them with those of patients with MTS.

Methods: We queried the Thomas Jefferson University Surgical Epilepsy Database for patients
who underwent anterior temporal lobectomy (ATL) from 1991-2009 and who had unilateral
temporal PET hypometabolism without an epileptogenic lesion on MRI (PET+/MRI-). We
compared this group to the group of patients who underwent ATL and who had MTS on MRI.
Patients with discordant ictal EEG were excluded. Surgical outcomes were compared using
percentages of Engel Class I outcomes at 2 and 5 years as well as Kaplan-Meier survival
statistic, with time to seizure recurrence as survival time. A subgroup of PET+/MRI- patients
who underwent surgical implantation prior to resection were compared to PET+/MRI- patients
who went directly to resection without implantation.

Key Findings: There were 46 PET+/MRI- patients (of whom 36 had 2-year surgical outcome
available) and 147 MTS patients. There was no difference between the two groups with regard to
history of febrile convulsions, generalized tonic-clonic seizures, interictal spikes, depression, or
Deleted: Mean

family history. Mean age at first seizure was higher in PET+/MRI- patients (19±13 vs.14±13
years, Mann-Wittney test, p=0.008) and disease duration was shorter (14 years±10 vs. 22±13,
Deleted: Median age at first seizure
was higher in PET+/MRI- patients (18.5,
IQR 8 to 28 vs. 10, IQR 4.75 to 18 years).

student’s t test, p=0.0006) Class I surgical outcomes did not differ significantly between the
PET+/MRI- patients and the MTS group (percentages of 2 and 5 year outcomes were 76% and
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75% for the PET+/MRI- group, and 71% and 78% for the MTS group); neither did outcomes of
the PET+/MRI- patients who were implanted prior to resection versus those who went directly to
surgery (implanted patients had 71% and 67% Class I outcomes at 2 and 5 years, while
nonimplanted patients had 77% and 78% Class I outcomes, p=0.66 and 0.28). Kaplan-Meier
survival statistics for both comparisons were nonsignificant at five years. Dentate gyrus and hilar
cell counts obtained from pathology for a sample of patients also did not differ between groups.

Significance: PET-positive, MRI-negative TLE patients in our study had excellent surgical
outcomes after ATL, very similar to those in patients with MTS, regardless of whether or not
they undergo intracranial monitoring. These patients should be considered prime candidates for
ATL, and intracranial monitoring is probably unnecessary in the absence of discordant data.

Key words: nonlesional, presurgical evaluation, postoperative outcomes,
fluorodeoxyglucose, positron emission tomography, temporal lobectomy, depth electrode,
implantation
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INTRODUCTION

FDG-PET (fluorodeoxyglucose positron emission tomography) imaging was the first imaging
modality found to be useful in the surgical evaluation of temporal lobe epilepsy (TLE). Magnetic
Resonance Imaging (MRI) has now supplanted PET as the primary imaging tool used in the
presurgical evaluation of TLE because of its high sensitivity (97%) and specificity (83%) for
hippocampal sclerosis (HS), the most common pathological basis of TLE (Berkovic 1995).
While it is established that mesial temporal sclerosis (MTS), the MRI correlate of HS, is the most
reliable predictor of good surgical outcome (Bercovic 1995, Spencer 2005), only 58-72% of
patients with TLE have MTS on MRI, with 16% of drug-resistant TLE patients demonstrating no
MRI abnormality at all (Berkovic 1995) This leaves a sizable minority of TLE patients to be
localized with other measures, including PET and intracranial monitoring.

At many epilepsy centers, interictal PET imaging is routinely used in the presurgical evaluation
of TLE patients, as hypometabolism on FDG-PET has been shown to correlate with good
surgical outcome (Willmann et al 2007). This empirical finding notwithstanding, we know little
about the etiology of PET hypometabolism in these patients. Studies that correlate PET with
pathology have found that the severity of cell loss in HS does not correspond to the degree of
PET hypometabolism (Foldvary 1999, Obrien 2007). It also appears that the pattern of temporal
PET hypometabolism does not correspond to the severity of temporal atrophy or MTS on MRI
(Chassoux 2004), and indeed the overall pattern rather than degree of focal hypometabolism
predicts successful surgical outcome (Dupont 2000). Despite these differences between MRI
and PET for presurgical evaluation, the asymmetry index for focal hypometabolism in the mesial
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temporal lobe is higher patients who attain seizure freedom postoperatively (Delbeke 1996). PET
hypometabolism ipsilateral to scalp EEG onset also has a high correlation with intracranial EEG
onset, which caused Engel to conclude that those patients may go on to surgery without
intracranial monitoring (Engel 1990). This conclusion predated the era of modern MRI scanning,
however.

Thus, the question remains whether PET positive, MRI negative patients should undergo
intracranial EEG monitoring, or whether they may proceed directly to surgical resection if all
other data is concordant. One case-control study matched 30 such PET positive, MRI negative
patients who underwent standard or hippocampal-sparing resections to 30 age and gender
matched patients with MTS on MRI, concluding that surgical outcome was equivalent between
groups (Carne et al 2004). At our center, 28 PET positive, MRI negative cases were reviewed
and found to have excellent surgical outcomes, although intracranially implanted patients were
excluded (Mintzer 2004). The purpose of our study is to compare surgical outcomes in a large
group of PET positive, MRI negative patients to those with MTS on MRI, as the latter is the
group with most established excellent surgical outcome. We also included those who underwent
intracranial electrode implantation, with the goal of determining whether invasive monitoring
altered surgical outcomes in this group of patients.

METHODS

Approval for a retrospective study was obtained from our institutional review board. We queried
the Thomas Jefferson Surgical Database from the Comprehensive Epilepsy Center for patients
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who underwent standard anterior temporal lobectomy (ATL) from 1991-2009. We selected 1991
as a cutoff point because of lesser MRI quality prior to 1991 resulting in decreased sensitivity to
MTS. Historical data, MRI, PET, aura and seizure types, interictal and ictal EEG, history of
depression, and follow up data were obtained from the database, which is prospectively
maintained. The methods of presurgical evaluations at our center have been previously described
Deleted: as unilateral

(Sperling et al 1996, Chandrasekar et al 2007). PET hypometabolism was defined qualitatively
Deleted: decreased tracer uptake in the
temporal lobe

by visual inspection of a consensus of radiologists and epileptologists at surgical conference.

Selection and Exclusion Criteria

We divided the patients into two groups: (1) PET+/MRI-, consisting of patients who had
temporal PET hypometabolism ipsilateral to the surgical site and an MRI without an
epileptogenic lesion (as described below), and (2) MTS, consisting of patients who had MRI
findings of hippocampal atrophy, with or without increased mesial temporal signal intensity. We
also queried the database for patients with the above imaging criteria who underwent intracranial
implants only, who did not undergo surgery, or who underwent nonstandard ATL instead.

In order to limit the study to patients who were likely to have true TLE, we excluded patients
with risk factors for multifocal epilepsy, including severe head injury with loss of consciousness,
cerebral anoxia, central nervous system infection, or stroke. Patients with brain tumors on
imaging or histopathology were also excluded, as the progressive nature of these conditions
separates them from other TLE etiologies with regard to prognosis. We also excluded patients
who had any extratemporal MRI findings that were potentially epileptogenic, including
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hemiatrophy, stroke, encephalomalacia, or other cortical lesions. Patients who had PET
hypometabolism in regions other than the temporal lobe, thalamus or cerebellum (as the latter
two regions are commonly hypometabolic in TLE patients (Theodore et al 1987, Henry et al
1993)), were excluded as well. Non-specific white matter lesions typical of migraine or mild
microvascular disease, and generalized brain atrophy were not considered exclusion criteria.
Finally, we excluded patients who had ictal scalp EEG findings that were extratemporal,
posterior temporal, or contralateral to the imaging abnormality.

Hippocampal Pathology

Owing to the age of much of the patient cohort and limitations of the dataset, reliable
histopathologic data for the majority of our patients could not be obtained.
However, in addition to the information obtained from our surgical database, we were able to
locate hilar neuron densities and dentate gyrus granule cell densities for a sample of our patients
from 1992-1997. The methods have been previously described elsewhere (Dlugos 1999). Eight
patients in the PET+/MRI- group and six patients from our MTS group had available data.

Statistical Analysis

Deleted: as

Student’s t test or Mann-Wittney test (for nonparametric variables) were used to compare age at
surgery, age at disease onset, disease duration and mean hilar neuron and dentate granule cell
densities between both groups. To compare the categorical variables, including febrile
convulsions, a family history of epilepsy, gender, laterality, history of depression, seizure type
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and handedness, we used the Fisher’s Exact test or Chi-Squared tests as applicable. To compare
surgical outcomes, in addition to comparing percentages of patients with Class I outcomes at 2
and 5 years postoperatively with Fisher's Exact Test, we used Kaplan-Meier analysis with
seizure free time as “survival time”. Statistical analysis was performed with WinSTAT software
[version 2009.1 R. Fitch, Germany].

RESULTS

A total of 193 patients met inclusion criteria and underwent standard ATL, with 46 patients
Deleted: Mean

included in the PET+/MRI- group, and 147 patients in the MTS group. Mean age at first seizure
was higher in PET+/MRI- patients (19±13 vs.14±13 years, Mann-Wittney test, p=0.008) and
disease duration was shorter (14 years±10 vs. 22±13, student’s t test, p=0.0006) The groups were

Deleted: Median age of seizure onset
was later in the PET+/MRI- group (18.5,
IQR 8 to 28 vs. 10, IQR 4.75 to 18 years).

not significantly different with regard to, history of febrile convulsions, presence of generalized

Deleted: (19±13 vs.14±13 years,
Student’s t test, p=0.026).

tonic clonic seizures, history of depression, family history of epilepsy, handedness or surgical

Deleted: disease duration, age at
surgery

side (Table 1).

The mean total years of postsurgical follow up were 5.4 for all patients (5.1 for the MTS patients
and 6.3 for the PET+/MRI- patients). Of the PET+/MRI- patients, 36 had two or more years of
follow up and 23 had five or more years of follow up; of the MTS patients, 115 had two or more
and 71 had five or more years of follow up. In addition to the 193 patients who underwent
surgical resection, an additional 33 patients (14.6%) in either group either had no surgery,
underwent nonstandard ATL or underwent implantation without proceeding to surgical resection.
Of the total group of 226 patients, 73% went directly to surgical resection and 12% underwent
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implantation prior to resection. (These are summarized in Table 2.) Of the PET+/MRI- patients
who underwent depth electrode implantation, 6/7 were performed before 1999, whereas the
nonimplanted patients were equally split between the two decades.

A summary of the presence and types of auras among the two groups is given in Table 3. The
only noteworthy difference in aura type appeared to be the presence of cognitive auras (including
déjà vu, forced thoughts, or other cognitive phenomena), which were found in 8/46 (17%) of
PET+/MRI- patients and in 9/145 (6%) of MTS patients (p = 0.058).

Class I surgical outcomes at 2 and 5 years were 76% and 75% for PET+/MRI- patients and 71%
and 78% for MTS patients (p=0.68 for 2 years, 0.78 at 5 years using Fisher's Exact Test). The
Kaplan-Meier survival curves using time to any seizure recurrence as a first event were not
statistically different between PET+/MRI- patients and MTS patients at five years (p=0.44, see
figure 1). In addition, the surgical outcomes between PET+/MRI- patients who underwent
intracranial implantation prior to resection and those who did not were also similar:
nonimplanted patients had 77% and 78% Class I outcomes at 2 and 5 years, respectively, and
implanted patients had 71% and 67% percent Class I outcomes at 2 and 5 years (p=0.66 and
0.28 at 2 and 5 years). The Kaplan-Meier probability statistic for implanted versus nonimplanted
patients was nonsignificant at p=0.9 (See figure 2).

Subanalyses were performed with regard to interictal EEG characteristics and with regard to
hippocampal neuron densities. Detailed information on interictal spikes on scalp EEG recording
was reviewed for 186 patients (Table 4). Patients were categorized into concordant, discordant
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and null (no interictal spikes) groups. Patients with concordant interictal spikes were defined as
having the majority of spikes (greater than 50%) seen in the ipsilateral sphenoidal, mid-temporal,
inferior temporal or frontotemporal electrodes, with few or no extratemporal spikes. Patients who
Deleted: The majority of patients in
both PET+/MRI- and MTS groups had
concordant spikes, without an identifiable
pattern of discordant spikes in the former
group compared to the latter.

had interictal spikes not meeting these criteria were categorized as discordant. The majority of
patients had concordant spikes (84% in the PET+/MRI- group, 86% in the MTS group). Of the
discordant spikes in either group, there was no identifiable pattern to their locations – ie,
PET+/MRI- patients did not appear to have in excess a posterior temporal or contralateral
discordant interictal spike focus (see Table 4). A Kaplan-Meier survival analysis using time to
first postoperative seizure recurrence was performed for patients in the PET+/MRI- group with
concordant and discordant interictal spikes, which revealed no difference in postoperative
surgical outcomes in those patients who had discordant interictal spike discharges (Figure 3). For
the histopathological analysis, PET+/MRI- patients were similar to MTS patients in terms of
their mean hilar neuron and dentate gyrus granule cell densities (dentate granule cell densities
were 123,553 ± 64,494 for PET+/MRI- patients and 120,646 ± 56,776 for MTS patients, and
hilar neuron densities were 2461± 2381 for PET+/MRI- patients and 2758±2600 for MTS
patients, units in cells/mm3, p=NS).

Further review of PET+/MRI- patients who underwent intracranial monitoring without
subsequent resection revealed two patients who were thought to have frontal seizures prior to
implantation; one of these was eventually determined to have seizures arising from Broca’s area,
while the other had seizures which could not be localized on intracranial EEG. A third patient
had anterior and posterior temporal interictal spikes on the right while ictal scalp EEG localized
to the left; implantation revealed bitemporal seizures. Two other patients had non-localized ictal
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scalp EEG which was not adequately localized after implantation.

In order to ensure that the survival analysis was not biases by differential dropout of
Deleted: D

particular groups of patients, demographic data including age of disease onset, disease duration,
gender, handedness, laterality, family history of epilepsy and history of GTC seizures and the
concordance of interictal spikes were compared between the patients who fell out of the survival
analysis (ie, patients with five or fewer years of follow up who did not have a seizure recurrence)

Deleted: PET+/MRI- patients who
were seizure free at five years and those
who were not (See Table 5). No
statistically significant differences could
be found.

in the PET+/MRI- and MTS groups. No significant differences between those groups were
found.

DISCUSSION

We report the outcome of a large group of PET positive, MRI negative patients, with comparison
of surgical outcomes in these patients to those in patients with mesial temporal sclerosis on MRI.
Furthermore, we directly compared the surgical outcomes of patients who underwent surgical
electrode implantation prior to resection to patients who did not. The mean and median follow up
times for our patients were at least 4 years, thus providing good long term data on surgical
outcome for a little-studied group, and allowing for survival analysis between groups.

Our study robustly showed that the PET+/MRI- group of patients have excellent postsurgical
outcomes, with 75% categorized as Class I at 5 years. In particular, the five-year surgical
outcomes for these patients were quite comparable to those of patients with MTS on MRI. These
Deleted: study

findings corroborate those found in a previous studies (Carne et al 2004, Struck et al 2011) and
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provide further evidence that the PET+/MRI- patients are very good surgical candidates.

In some centers, this group of patients generally undergoes intracranial implantation due to the
absence of a structural abnormality. The PET+/MRI- patients in our center had a low rate of
surgical implanation, yet still had excellent outcomes. Furthermore, those patients who were
implanted surgically had equivalent outcomes to those who went directly to resection, with
Kaplan-Meier survival outcomes having no significant difference at five years. Thus, it is likely
unnecessary to undertake expensive and invasive surgical implantation for many otherwise
uncomplicated cases of temporal lobe epilepsy with concordant PET and EEG, even when MRI
is negative.

Further review of our PET+/MRI- patients who did not undergo resection after implantation
showed that for most, their presurgical workup had relevant pieces of discordant or ambiguous
data that made them less than ideal candidates for resection despite their concordant PET and
ictal EEG findings. Thus, while most PET+/MRI- TLE patients may likely proceed directly to
resection, there are some for whom intracranial monitoring may still be appropriate. In our
patient population, the PET+/MRI- patients who were implanted and underwent surgery were
mostly earlier cases, which is probably a result of more conservative practices in years past.
Since we have found that those implanted patients who otherwise fit our criteria did well, it
appears that a less stringent approach has been appropriate.

Another clinical implication from our findings is that any MRI-negative patient with TLE should
be considered for a PET study. A recent meta-analysis showed that MRI-negative epilepsy
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patients had a significantly lower seizure-free outcome compared to lesional cases (TéllezZenteno et al 2010), but this does not preclude finding particular subgroups of MRI-negative
epilepsy in whom surgical prognosis is better; our data suggest that PET+/MRI- patients without
discordant data should have much higher rates of seizure freedom, likely equivalent to the
lesional group. Among predictive factors for seizure outcome on a series of MRI negative
patients, non-congruent PET was the strongest predictive factor for an Engel Class of III or IV
(Immonen et al, 2010); this suggests that a PET scan may be considered to rule out candidates
for surgery as well.

Our study is limited by the retrospective design, as is the case for most surgical outcome studies.
Carrying out a prospective study for epilepsy surgery in which individualized judgments are
superseded by randomization is not feasible, given the complexities of individual cases. We
attempted to minimize the biases of complex cases by limiting our data to groups of “clean”
cases with minimal discordant data and without risk factors for multifocality. We did include
patients with discordant interictal spike discharges, as bitemporal spikes are commonly seen in
TLE; but discordant interictal spikes did not correlate with worse surgical outcomes in our
PET+/MRI- patients, nor was there a difference in distribution of interictal spikes between the
PET+/MRI- patients and classic MTS patients. It is also worth noting that for those patients who
did not undergo surgery — which occurred more frequently in the PET+/MRI- group — it is
possible that there might have been similarly good postoperative outcomes had resections been
pursued.

The two other limitations to our study are the absence of neuropsychological data detailing
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cognitive outcomes for this group and histopathological diagnoses. Raw neuropsychological data
for many of the patients operated on during the 1990's was not available, but a further analysis is
being performed for a subset of patients and will be reported separately. Since clinicians often
hesitate to resect a dominant nonlesional temporal lobe because of a theoretical potential for
verbal memory dysfunction, this data will help guide practicioners on whether or not to implant
the dominant PET+/MRI- patient based on actual postoperative cognitive outcomes. Regarding
histopathologic data, while diagnoses were not available for most patients, we were able to
obtain hippocampal cell density data for a small subgroup and found no difference in
hippocampal cell densities in the regions of the hilum and dentate gyrus between the patients
with MTS and the patients with temporal PET hypometabolism and normal MRI. These data
provide further evidence that the distinction between MRI+ and MRI-/PET+ patients with TLE is
likely not a function of differences in hippocampal cell density (Foldvary 1999, Obrien 2007,
Dlugos 2009).

The underlying etiology of PET+/MRI- TLE continues to be enigmatic. Carne et al found
differences in the history of febrile convulsions and presence of hippocampal sclerosis, and
concluded that their patients appeared to be a surgically remediable syndrome which was distinct
from MTS (Carne et al 2004). The only significant clinical differences we found between these
patients and those with MTS is that the PET+/MRI- patients developed epilepsy at a later age
and had shorter disease durations at time of surgery, along with a trend towards more cognitive
auras. While our results would indeed suggest that these patients are largely surgically
remediable, their distinction as a homogeneous clinical entity is not supported by our findings. In
fact, recent reports together have found heterogeneous causes of PET+/MRI- epilepsy such as
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small temporal pole encephaloceles (Abou-Hamden et al 2010) or Taylor-type focal cortical
dysplasias (Chassoux et al 2010). Interestingly, a recent series showed that only one of three
MRI- patients with HS had lateralized PET hypometabolism (Bien et al 2009); thus, it would
appear that PET hypometabolism does not result from HS. In that same series, the MRI- patients
categorized as indefinite histopathology who had lateralized PET had nonspecific irregularities
of hippocampal architecture such as blurring of the gray-white matter junctions, gliosis or
heterotopic neurons (Bien et al 2009, personal communication). Thus, it is possible that the
PET+/MRI- TLE group represents a milder form of hippocampal abnormality than classic HS
that is nonetheless equally remediable to surgical treatment.
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FIGURE LEGENDS
Figure 1. Kaplan-Meier survival plot of probability of postoperative seizure freedom in
PET+/MRI- patients versus MTS patients, with survival as time to first seizure recurrence. No
statistically significant difference was seen.

Figure 2. Probability of postoperative seizure freedom in PET+/MRI- patients who underwent
surgical EEG electrode implantation prior to resection versus those who went directly to surgical
resection. There was no difference in surgical outcomes.

Figure 3. Probability of postoperative seizure freedom in PET+/MRI- patients with concordant
versus discordant interictal spike discharges. There was no difference in surgical outcomes
between the two groups.
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TABLES
Table 1. Summary of Demographic Data
PET+/MRIpercent

MTS

Total number of subjects

number
46

Age of onset (mean in years)

number
147

p value

19

14

0.008

Age at surgery

34

36

0.567

Disease Duration

14

22

0.0006

History of GTC seizures

percent

52%

24

65%

97

0.091

Men
Women

41%
59%

19
27

44%
56%

65
82

0.865

Seizure lateralization
Right
Left

43%
57%

20
26

53%
47%

78
69

0.311

Handedness
Right
Left
Ambidextrous
Nonresponders

85%
15%
0%

39
7
0
0

85%
13%
1%

125
19
2
1

0.888

Family history of Epilepsy
Positive
Negative
Unknown

24%
63%

11
29
6

91%
63%

42
92
13

0.699

30%
65%

14
30
2

44%
56%

64
84
1

0.167

History of Depression

35%

16

32%

47

0.72

Number of subjects who
underwent intracranial
monitoring

15%

7

14%

21

0.815

Deleted: 026

Gender

History of Febrile
Convulsions
Positive
Negative
Nonresponders
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Table 2. Patients fulfilling study criteria who did not undergo standard resection or only
underwent surgical EEG electrode implantation.
Direct to surgery
Intracranial monitoring proceeding to standard ATL
no surgery
modified ATL
Intracranial monitoring without proceeding to
resection
total

PET+/MRI39

percent
67%

MTS
126

percent
75%

7
5
2

12%
9%
3%

21
5
11

12%
3%
7%

5
58

9%

5
168

3%
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Table 3. Auras in PET+/MRI- patients and MTS patients
PET+/MRIn=46
% without auras
% with auras
type:
cognitive, déjà vu or forced
thought auras
epigastric/thoracic
nausea

MTS
n=145

p value

21.7%
78.3%

29.0%
71.0%

0.337

17.4%
17.4%
10.9%

6.2%
21.4%
11.0%

0.058
0.41
0.612
0.243

"indescribable feeling"

15.2%

7.6%

other

17.4%

24.9%
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Table 4. Interictal Spike Data
Number with concordant interictal spikes
Number with discordant interictal spikes
discordant contralateral temporal
discordant ipsilateral anterior
discordant ipsilateral posterior
discordant contralateral extratemporal
bitemporal
discordant hemispheric
Null (no interictal spikes)
Totals

PET+/MRI-

MTS

37
4

122
14
1
2
1
0
0
0

3
44

4
2
3
1
2
2
6
142
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